Institute of Bioengineering, School of Life Sciences, École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland.
Department of Pharmaceutical Sciences, University of Perugia, Perugia, Italy.
Gastroenterology. 2020 Sep;159(3):956-968.e8. doi: 10.1053/j.gastro.2020.05.067. Epub 2020 May 30.
BACKGROUND & AIMS: Renewal and patterning of the intestinal epithelium is coordinated by intestinal stem cells (ISCs); dietary and metabolic factors provide signals to the niche that control ISC activity. Bile acids (BAs), metabolites in the gut, signal nutrient availability by activating the G protein-coupled bile acid receptor 1 (GPBAR1, also called TGR5). TGR5 is expressed in the intestinal epithelium, but it is not clear how its activation affects ISCs and regeneration of the intestinal epithelium. We studied the role of BAs and TGR5 in intestinal renewal, and regulation of ISC function in mice and intestinal organoids.
We derived intestinal organoids from wild-type mice and Tgr5 mice, incubated them with BAs or the TGR5 agonist INT-777, and monitored ISC function by morphologic analyses and colony-forming assays. We disrupted Tgr5 specifically in Lgr5-positive ISCs in mice (Tgr5 mice) and analyzed ISC number, proliferation, and differentiation by flow cytometry, immunofluorescence, and organoid assays. Tgr5 mice were given cholecystokinin; we measured the effects of BA release into the intestinal lumen and on cell renewal. We induced colitis in Tgr5 mice by administration of dextran sulfate sodium; disease severity was determined based on body weight, colon length, and histopathology analysis of colon biopsies.
BAs and TGR5 agonists promoted growth of intestinal organoids. Administration of cholecystokinin to mice resulted in acute release of BAs into the intestinal lumen and increased proliferation of the intestinal epithelium. BAs and Tgr5 expression in ISCs were required for homeostatic intestinal epithelial renewal and fate specification, and for regeneration after colitis induction. Tgr5 mice developed more severe colitis than mice without Tgr5 disruption in ISCs. ISCs incubated with INT-777 increased activation of yes-associated protein 1 (YAP1) and of its upstream regulator SRC. Inhibitors of YAP1 and SRC prevented organoid growth induced by TGR5 activation.
BAs promote regeneration of the intestinal epithelium via activation of TGR5 in ISCs, resulting in activation of SRC and YAP and activation of their target genes. Release of endogenous BAs in the intestinal lumen is sufficient to promote ISC renewal and drives regeneration in response to injury.
肠道上皮的更新和模式形成由肠道干细胞(ISCs)协调;饮食和代谢因素为肠道提供信号,以控制 ISC 的活性。胆汁酸(BAs)是肠道中的代谢物,通过激活 G 蛋白偶联胆汁酸受体 1(GPBAR1,也称为 TGR5)来信号营养物质的可用性。TGR5 在肠道上皮中表达,但尚不清楚其激活如何影响 ISC 和肠道上皮的再生。我们在小鼠和肠道类器官中研究了 BAs 和 TGR5 在肠道更新和 ISC 功能调节中的作用。
我们从野生型小鼠和 Tgr5 小鼠中分离出肠道类器官,用 BAs 或 TGR5 激动剂 INT-777 孵育,通过形态分析和集落形成测定监测 ISC 功能。我们在 Lgr5 阳性 ISC 中特异性敲除了 Tgr5(Tgr5 小鼠),并通过流式细胞术、免疫荧光和类器官测定分析 ISC 数量、增殖和分化。给 Tgr5 小鼠注射胆囊收缩素;我们测量了 BA 释放到肠腔中和对细胞更新的影响。我们通过给予葡聚糖硫酸钠诱导 Tgr5 小鼠结肠炎;根据体重、结肠长度和结肠活检的组织病理学分析来确定疾病的严重程度。
BAs 和 TGR5 激动剂促进了肠道类器官的生长。给小鼠注射胆囊收缩素会导致 BAs 急性释放到肠腔中,并增加肠道上皮细胞的增殖。ISCs 中的 BAs 和 Tgr5 表达对于肠道上皮的稳态更新和命运特化以及结肠炎诱导后的再生是必需的。与没有在 ISC 中破坏 Tgr5 的小鼠相比,Tgr5 小鼠发展出更严重的结肠炎。用 INT-777 孵育的 ISC 会增加 YAP1 及其上游调节因子 SRC 的激活。YAP1 和 SRC 的抑制剂可阻止 TGR5 激活诱导的类器官生长。
BAs 通过激活 ISC 中的 TGR5 促进肠道上皮的再生,导致 SRC 和 YAP 的激活及其靶基因的激活。肠腔中内源性 BAs 的释放足以促进 ISC 更新,并在响应损伤时驱动再生。